Table 4 Adverse events occurring in ≥10% of subjects in any treatment group
Event, n(%) | 8 mg (n= 31) | 16 mg (n= 31) | 32 mg (n= 31) | 64 mg (n= 32) |
|---|---|---|---|---|
Asthenia | 2 (6) | 5 (16) | 3 (10) | 5 (16) |
Nausea | 4 (13) | 5 (16) | 3 (10) | 3 (9) |
Headache | 2 (6) | 3 (10) | 5 (16) | 3 (9) |
Chest pain | 0 (0) | 0 (0) | 3 (10) | 2 (6) |